Product Name | MF | CAS | Details |
---|
(2-Azidoethyl)[3-(dimethylamino)propyl]methylamine dihydrochloride | C8H20ClN5 | 1432681-85-0 | Details |
1-[(tert-Butoxy)carbonyl]-3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)azetidine-3-carboxylic acid | C24H26N2O6 | 1380327-51-4 | Details |
PDIA3 antibody | Details |
MTHFSD antibody | Details |
1-[(Dimethyl-4H-1,2,4-triazol-3-yl)methyl]piperazine | C9H17N5 | 1154708-01-6 | Details |
AZD0156 | C26H31N5O3 | 1821428-35-6 | Details |
1-tert-Butyl 4-Methyl 4-(Hydroxymethyl)piperidine-1,4-dicarboxylate | C13H23NO5 | 1006044-27-4 | Details |
LSN 2463359 | C16H15N3O | 1401031-52-4 | Details |
2-(Carboxymethyl)-4,5-dimethoxybenzoic acid | C11H12O6 | 3809-00-5 | Details |
Neotame monohydrate | C20H32N2O6 | 243116-62-3 | Details |
RAB7L1 antibody | Details |
5-Methyl-3-(2-oxopropyl)-2,3-dihydro-1,3,4-oxadiazol-2-one | C6H8N2O3 | 136738-11-9 | Details |
1-(Cyclopropylmethyl)piperidine-4-carboxylic acid hydrochloride | C10H18ClNO2 | 1158595-41-5 | Details |
Palladium, [1,3-bis[2,6-bis(1-methylethyl)phenyl]-1,3-dihydro-2H-imidazol-2-ylidene]dichloro(1-methyl-1H-imidazole-kN3)-, (SP-4-1)- | C31H42Cl2N4Pd | 1314876-23-7 | Details |
[1-(2-Bromophenyl)ethyl](2-methylpropyl)amine | C12H18BrN | 1019628-97-7 | Details |
N-Boc-4-iodo-L-phenylalanine methyl ester ee | C15H20INO4 | 113850-76-3 | Details |
Thevetiaflavone | C16H12O5 | 29376-68-9 | Details |
2-(Carbamoylamino)-3,3-dimethylbutanoic acid | C7H14N2O3 | 463943-04-6 | Details |
1-(Pyridine-4-carbonyl)piperidine-3-carboxylic acid | C12H14N2O3 | 67691-63-8 | Details |
Fmoc-beta-cyclohexyl-D-alanine | C24H27NO4 | 144701-25-7 | Details |
3-(tert-Butoxy)spiro[3.3]heptan-1-amine | C11H21NO | 1935154-10-1 | Details |
6-Chloro-2,3,4,9-tetrahydro-1H-carbazol-3-amine | C12H13ClN2 | 147008-96-6 | Details |
m-dPEG?8-Azide (Azido-m-dPEG?8) | C17H35N3O8 | 869718-80-9 | Details |
3-(2,6-Difluorophenyl)-1,2-oxazole-5-carboxylic acid | C10H5F2NO3 | 1152531-95-7 | Details |
GC2 protein | Details |
tert-butyl N-(4-aminophenyl)-N-methylcarbamate | C12H18N2O2 | 1092522-02-5 | Details |
H-FSGSGSGTDFTLK-OH | Details |
2-(5-Amino-3-methyl-1H-pyrazol-1-yl)-6-methyl-3,4-dihydropyrimidin-4-one | C9H11N5O | 79871-76-4 | Details |
[1-(2-bromophenyl)cyclopropyl]methanamine | C10H12BrN | 886365-59-9 | Details |
H-LLDVDNR^-OH | Details |
(2-Methyl-4-propoxyphenyl)methanol | C11H16O2 | 1254062-63-9 | Details |
4-(Phenylsulfanyl)benzene-1,3-diamine | C12H12N2S | 6264-74-0 | Details |
(2S)-1,4-dioxane-2-carboxylic acid | C5H8O4 | 1821739-82-5 | Details |
[(4-Methyl-furazan-3-carbonyl)-amino]-acetic acid | C6H7N3O4 | 797806-70-3 | Details |
6-Chloro-3-methyl-1H-indole | C9H8ClN | 158905-35-2 | Details |
D-Allose-6-phosphate disodium | C6H14NaO9P | 1161976-98-2 | Details |
4'-Methylpropiophenone | C10H12O | 5337-93-9 | Details |
3-[2-(2-propynyloxy)phenyl]acrylic acid | C12H10O3 | 400751-66-8 | Details |
4-Nitrophenyl O-(N-acetyl-a-neuraminosyl)-(2-3)-b-D-galactopyranosyl-(1-4)-b-D-glucopyranoside | C29H42N2O21 | 1611491-05-4 | Details |
[1-(1H-Pyrazol-3-yl)cyclobutyl]methanol | C8H12N2O | 2228570-93-0 | Details |
Penicillic Acid | C8H10O4 | 90-65-3 | Details |
5-(Chloromethyl)-4-methyl-2-phenyl-1,3-thiazole hydrochloride | C11H11Cl2NS | 2375273-77-9 | Details |
Cell-permeable Caspase-1 Inhibitor I trifluoroacetate salt | C97H160N20O24 | 201608-12-0 | Details |
4-(4-Bromophenyl)-2-chloropyrimidine | C10H6BrClN2 | 932162-80-6 | Details |
Ano6 Blocking Peptide | Details |
Amyloid Bri Protein (1-23) trifluoroacetate salt | C116H175N31O35S2 | 717122-86-6 | Details |
5-[3-(Dimethylamino)propyl]-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ol | C20H25NO | 1159-03-1 | Details |
1-Boc-3-cyano-3-methylazetidine | C10H16N2O2 | 936850-09-8 | Details |
3-Fluoropiperidine-4-carboxylic acid hydrochloride | C6H11ClFNO2 | 1781035-24-2 | Details |
3-(4-Methylphenyl)-5-({[4-(4-methylphenyl)-5-(pyrrolidin-1-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}methyl)-1,2,4-oxadiazole | C23H24N6OS | 920829-44-3 | Details |
Methyl 2-(4-amino-1H-indol-1-yl)acetate | C11H12N2O2 | 1343385-31-8 | Details |
5-(Piperidin-4-yl)isoquinoline dihydrochloride | C14H17ClN2 | 1803587-27-0 | Details |
5-Thiocyanato-thiazol-2-ylamine | C4H3N3S2 | 23056-10-2 | Details |
3-(Aminomethyl)-6,6,6-trifluorohexan-3-ol hydrochloride | 2138414-79-4 | Details |
1,3,5-Triisopropylbenzene | C15H24 | 717-74-8 | Details |
Histone H4 antibody | Details |
N-Benzyl-3-(trifluoromethyl)oxolan-3-amine | C12H14F3NO | 1638269-36-9 | Details |
PAK1 antibody (Thr212) | Details |
2-Ethylhexyl-D-xylopyranoside | C13H26O5 | 185699-11-0 | Details |
(1-Phenylpentan-2-yl)(propyl)amine | C14H23N | 119485-94-8 | Details |
N-(2-Aminoethyl)-4-phenylbutanamide hydrochloride | C12H19ClN2O | 861052-88-2 | Details |
2'-Azido-2'-deoxyguanosine | C10H12N8O5 | 60921-30-4 | Details |
FCRLB antibody | Details |
H-VVFDDTYDR-OH | Details |
6-Chloro-N-methylpyridazin-4-amine | C5H6ClN3 | 17645-08-8 | Details |
2,4-Dimethyl-2H,6H,7H-pyrazolo[3,4-b]pyridin-6-one | C8H9N3O | 73810-75-0 | Details |
CD200 protein (His tag) | Details |
6-(Piperidine-4-carbonyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one hydrochloride | C14H17ClN2O3 | 420786-43-2 | Details |
3-Chloro-N-(2-chlorobenzyl)propanamide | C10H11Cl2NO | 103038-66-0 | Details |
Recombinant Human IFN-alpha 2a | Details |
1-Methyl-6-oxo-2-phenylpiperidine-3-carboxamide | C13H16N2O2 | 1311317-10-8 | Details |
2-(3-Ethoxypropyl)-2,3-dihydro-1H-isoindol-5-amine | C13H20N2O | 1094628-11-1 | Details |
GGT2 Blocking Peptide | Details |
Bisoprolol | C22H35NO8 | 105878-43-1 | Details |
(3aS, 7R, 9S, 9aR, 9bR) -9- [[(1, 1- Dimethylethyl) dimethylsilyl] oxy] - 2, 2- diethylhexahydro- 7- methyl-1, 3- Dioxolo[4, 5- a] i ndolizin- 6(4H) - one | Details |
8-Chloroquinoline-2-carboxylic Acid | C10H6ClNO2 | 915922-73-5 | Details |
7-Ethoxy-3,4-dihydro-2H-1,4-benzothiazin-3-one | C10H11NO2S | 71387-69-4 | Details |
4,6-Dimethylheptan-3-one | C9H18O | 40239-30-3 | Details |
3-{4H,5H,6H,7H-Thieno[3,2-c]pyridine-5-sulfonyl}aniline | C13H14N2O2S2 | 954564-58-0 | Details |
Phyllanthine | C14H17NO3 | 20072-02-0 | Details |
ATPase antibody | Details |
4-(Benzylcarbamoyl)butanoic acid | C12H15NO3 | 42856-45-1 | Details |
2-Amino-6-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-4H,5H,6H,7H-thieno[2,3-c]pyridine-3-carbonitrile | C14H10ClF3N4S | 321430-41-5 | Details |
2-(4-Methoxypyridin-3-yl)acetic acid hydrochloride | C8H10ClNO3 | 2094384-38-8 | Details |
[5-FAM]-C7 | Details |
Sesartemin | C23H26O8 | 77394-27-5 | Details |
5-(2,4-Dimethoxyphenyl)imidazolidine-2,4-dione | C11H12N2O4 | 79003-60-4 | Details |
4-[2-(Piperidin-4-yl)pyrimidin-4-yl]morpholine dihydrochloride | 2060043-11-8 | Details |
4-Azido-2-chloro-1-methylbenzene | C7H6ClN3 | 357292-37-6 | Details |
2-(3-Chlorophenyl)-2-[(2-methylpropyl)sulfanyl]ethan-1-amine hydrochloride | C12H19Cl2NS | 1311314-56-3 | Details |
Biotin reagent (HRP) | Details |
Methyl 2-{4-[1-(hydroxyimino)ethyl]phenoxy}acetate | C11H13NO4 | 1016680-52-6 | Details |
2-(Oxan-3-yl)-1H-imidazole | C8H12N2O | 1243164-60-4 | Details |
TMED3 Blocking Peptide | Details |
(+)-Episesamin | C20H18O6 | 133-03-9 | Details |
CMVpp65 - 82 (QIFLEVQAIRETVEL) | Details |
1,3-Dimethyl-5-(pyridin-2-ylsulfanyl)-1H-pyrazol-4-amine | C10H12N4S | 1157093-59-8 | Details |
(4-(dimethylamino)phenyl)-N-(2,3-dimethyl-5-oxo-1-phenyl(3-pyrazolin-4-yl))formamide | C20H22N4O2 | 1023498-20-5 | Details |
6-Methoxy-2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-4-one | C12H14O3 | 13229-59-9 | Details |
Product Total: Product Page: | ||||
41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 |